Receptra Pet Tincture, leveraging a full-spectrum CBD extract from organic, Colorado-grown hemp, showcases a robust cannabinoid profile. The most recent lab report for their 750mg tincture not only verifies the advertised CBD content at 771mg but also highlights an additional 105mg of cannabinoids, including CBC, CBDV, CBG, and THC.
This assortment of four extra cannabinoids surpasses the usual average of three found in CBD oils from an evaluation of over 30 brands, with its 14% additional cannabinoid content exceeding the average of 8%.
The lab report’s date, March 21st, 2022, offers relatively current product information, though an even more recent report would be ideal for the most accurate assessment.
The tincture is unflavored, consisting solely of a MCT carrier oil along with the CBD extract. Available in two concentrations – 480mg and 750mg – the range may not be extensive enough to suit all dog sizes or dosage needs.
Regarding pricing, Receptra Pet Tincture is a cost-effective option. At $0.07 per mg of CBD for the higher concentration and $0.08 for the lower, it is priced below the market average and provides good value for the money.
However, for Receptra’s Pet Tincture to truly compete with the more premium CBD oils for dogs, we would like to see a higher number of cannabinoids and a more up to date lab report.